Skip to main content
Fig. 1 | Biology of Sex Differences

Fig. 1

From: Polypharmacy in patients with multiple sclerosis: a gender-specific analysis

Fig. 1

Gender-specific polypharmacy rates dependent on comorbidities, patient care, disease duration, and school years. The patients (N = 306) were divided into four groups according to patient care (a), comorbidities (b), school years (c), and disease duration (d), respectively. Each partitioning was composed of two subgroups consisting of male and female MS patients. A univariate logistic regression analysis revealed no significant interaction effect between gender and patient care, comorbidities, school years, and disease duration, respectively (p > 0.15). Overall, there was no significant difference in the proportion of PwP between men and women (Fisher’s exact test: p = 0.799). MS, multiple sclerosis; p, p value; PwP, patients with polypharmacy; PwSI, patients with secondary illnesses; Pw/oSI, patients without secondary illnesses; Fi, Fisher’s exact test

Back to article page